ECRG4 and cancer: It has been shown that the ECRG4 promoter undergoes aberrant methylation which causes extinction of its expression in a variety of different human cancers, such as esophageal [24] and colorectal cancer [25], malignant glioma [26, 27], breast [28] and prostate cancer [29].